Advertise
NEWSLETTER
Serina advances SER-252 Par...
FDA accepts review for Nano...
MetaVia data show DA-1726 c...
Coya’s combination dr...
Alzheon reports Phase 3 win...
Serina advances SER-252 Par...
FDA accepts review for Nano...
MetaVia data show DA-1726 c...
Coya’s combination dr...
Alzheon reports Phase 3 win...
Matt Kaeberlein

Interviews of 2025: The innovators

Human trial finds therapeutic plasma exchange reduces biological age

David Sinclair resigns as President of the Academy for Health & Lifespan Research

David Sinclair resigns as President of the Academy for Health & Lifespan Research

We want to give you back 10-20 years of healthspan

‘We want to help people add 10-20 years of healthspan’

NIA’s decision to defund Dog Aging Project ‘unjust’

NIA’s decision to defund Dog Aging Project ‘unjust’

Interviews of 2023: the longevity visionaries

The new fluoride? FDA greenlights rapamycin oral health trial

The new fluoride? FDA greenlights rapamycin oral health trial

Does rapamycin extend lifespan in dogs? It’s time to find out. // Dog aging project update interview

Does rapamycin extend lifespan in dogs? It’s time to find out.

Rise of the WormBots: it’s time to scale up longevity R&D

The latest longevity science, investment, innovation and insight, delivered every morning.

This field is hidden when viewing the form